{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:44:24Z","timestamp":1792179864153,"version":"4.4.0"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this study was to assess the efficacy of low-dose atropine 0.01% in controlling myopia progression among Indian children over a 2-year period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study, conducted across 20 centres in India, monitored the progression of myopia over 2 years after initiating treatment with 0.01% atropine eye drops. This included children between 6 and 14 years with baseline myopia ranging from \u22120.5 D to \u22126 D, astigmatism\u2264\u22121.5 D, anisometropia \u2264 \u22121 D and documented myopia progression of \u22650.5 D in the year prior to starting atropine. Subjects with any other ocular pathologies were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 732 children were included in the data analysis. The mean age of the subjects was 9.3\u00b12.7 years. The mean myopia progression at baseline (1 year before starting atropine) was \u22120.75\u00b10.31 D. The rate of myopia progression was higher in younger subjects and those with higher baseline myopic error. After initiating atropine, myopia progression significantly decreased to \u22120.27\u00b10.14 D at the end of the first year and \u22120.24\u00b10.15 D at the end of the second year (p<jats:italic>&lt;<\/jats:italic>0.001). Younger children (p&lt;0.001) and higher baseline myopia (p&lt;0.001) was associated with greater myopia progression and poor treatment response (p&lt;0.001 for both).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Low-dose atropine (0.01%) effectively reduces myopia progression over 2 years in Indian children.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjo-2023-324450","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:20:55Z","timestamp":1706638855000},"page":"bjo-2023-324450","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-8632","authenticated-orcid":false,"given":"Rohit","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-4835","authenticated-orcid":false,"given":"Rebika","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Agarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Neena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damaris","family":"Magdalene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Jethani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra C","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Gogri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Gadaginamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradhnya","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Sukhija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti H","family":"Matalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7504-6447","authenticated-orcid":false,"given":"Anupam","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Nishanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-3979","authenticated-orcid":false,"given":"Shweta","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilutparna","family":"Deori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Bordoloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4497-9818","authenticated-orcid":false,"given":"Shailja","family":"Tibrewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Phuljhele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7542","authenticated-orcid":false,"given":"Namrata","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"2024013010201242000_bjo-2023-324450v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60272-4"},{"key":"2024013010201242000_bjo-2023-324450v1.2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/OPTH.S349393","article-title":"Myopia in India","volume":"16","author":"Pujari","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"2024013010201242000_bjo-2023-324450v1.3","doi-asserted-by":"crossref","unstructured":"Saxena R , Vashist P , Tandon R , et al . Incidence and progression of myopia and associated factors in urban school children in Delhi: the North India myopia study (NIM study). PLoS One 2017;12:e0189774. doi:10.1371\/journal.pone.0189774","DOI":"10.1371\/journal.pone.0189774"},{"key":"2024013010201242000_bjo-2023-324450v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006"},{"key":"2024013010201242000_bjo-2023-324450v1.5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1755-3768.1988.tb02673.x","article-title":"Ocular morbidity in myopia","volume":"185","author":"Goldschmidt","year":"1988","journal-title":"Acta Ophthalmol Suppl (1985)"},{"key":"2024013010201242000_bjo-2023-324450v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90416-5"},{"key":"2024013010201242000_bjo-2023-324450v1.7","doi-asserted-by":"crossref","unstructured":"Haarman AEG , Enthoven CA , Tideman JWL , et al . The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci 2020;61:49. doi:10.1167\/iovs.61.4.49","DOI":"10.1167\/iovs.61.4.49"},{"key":"2024013010201242000_bjo-2023-324450v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.11.010"},{"key":"2024013010201242000_bjo-2023-324450v1.9","unstructured":"Rosenfield M . Accommodation and myopia. In: Rosenfield M , Gilmartin B , eds. Myopia and nearwork. 12th ed. Oxford, United Kingdom: Butterworth-Heinemann, 1998: 91\u2013116."},{"key":"2024013010201242000_bjo-2023-324450v1.10","first-page":"205","article-title":"Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism","volume":"34","author":"McBrien","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024013010201242000_bjo-2023-324450v1.11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: multicentric randomized trial","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"2024013010201242000_bjo-2023-324450v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.062"},{"key":"2024013010201242000_bjo-2023-324450v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.031"},{"key":"2024013010201242000_bjo-2023-324450v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029"},{"key":"2024013010201242000_bjo-2023-324450v1.15","doi-asserted-by":"crossref","unstructured":"McCulloch CE , Neuhaus JM . Generalized linear mixed models. In: Encyclopedia of biostatistics. 2005. doi:10.1002\/0470011815","DOI":"10.1002\/0470011815.b2a10021"},{"key":"2024013010201242000_bjo-2023-324450v1.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2000.00645.x"},{"key":"2024013010201242000_bjo-2023-324450v1.17","doi-asserted-by":"crossref","unstructured":"Agarwal D , Saxena R , Gupta V , et al . Prevalence of myopia in Indian school children: meta-analysis of last four decades. PLoS One 2020;15:e0240750. doi:10.1371\/journal.pone.0240750","DOI":"10.1371\/journal.pone.0240750"},{"key":"2024013010201242000_bjo-2023-324450v1.18","doi-asserted-by":"crossref","unstructured":"Chen C , Yao J . Efficacy and adverse effects of atropine for myopia control in children: a meta-analysis of randomised controlled trials. J Ophthalmol 2021;2021:4274572. doi:10.1155\/2021\/4274572","DOI":"10.1155\/2021\/4274572"},{"key":"2024013010201242000_bjo-2023-324450v1.19","doi-asserted-by":"crossref","unstructured":"Gan J , Li S-M , Wu S , et al . Varying dose of atropine in slowing myopia progression in children over different follow-up periods by meta-analysis. Front Med (Lausanne) 2021;8:756398. doi:10.3389\/fmed.2021.756398","DOI":"10.3389\/fmed.2021.756398"},{"key":"2024013010201242000_bjo-2023-324450v1.20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","article-title":"Atropine SLOWS myopia progression more in Asian than white children by meta-analysis","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"},{"key":"2024013010201242000_bjo-2023-324450v1.21","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4103\/ijo.IJO_3157_20","article-title":"Efficacy of low-dose atropine to reduce myopia progression among Indian children","volume":"69","author":"Sivaraman","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2024013010201242000_bjo-2023-324450v1.22","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.4103\/ijo.IJO_2098_21","article-title":"Current concepts in the management of childhood myopia","volume":"70","author":"Dhiman","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"2024013010201242000_bjo-2023-324450v1.23","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.ophtha.2021.07.011","article-title":"Reply","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"2024013010201242000_bjo-2023-324450v1.24","doi-asserted-by":"crossref","first-page":"01081","DOI":"10.3389\/fphar.2020.01081","article-title":"Analysis of factors that may affect the effect of atropine 0.01% on myopia control","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024013010201242000_bjo-2023-324450v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.12.036"},{"key":"2024013010201242000_bjo-2023-324450v1.26","doi-asserted-by":"crossref","unstructured":"Chaurasia S , Negi S , Kumar A , et al . Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population. Sci Rep 2022;12:7113. doi:10.1038\/s41598-022-10079-1","DOI":"10.1038\/s41598-022-10079-1"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2023-324450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:21:16Z","timestamp":1706638876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2023-324450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":26,"alternative-id":["10.1136\/bjo-2023-324450"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2023-324450","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}